Myocardial Work by Speckle Tracking Echocardiography in Heart Transplant Recipients: Association between Global Work Efficiency and Coronary Allograft Vasculopathy.

Coronary Allograft Vasculopathy Heart Transplantation Myocardial Work Speckle Tracking Echocardiography

Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
23 Jul 2024
Historique:
received: 08 05 2024
revised: 15 06 2024
accepted: 17 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: aheadofprint

Résumé

Coronary allograft vasculopathy (CAV) is a leading cause of morbidity and mortality following heart transplantation. CAV is often diagnosed in later stages or during routine screening in asymptomatic subjects. Myocardial work (MW), calculated using left-ventricular global longitudinal strain (LV-GLS) and systemic blood pressure, may be associated with the presence of CAV and outperform conventional echocardiographic parameters. In this retrospective observational study, heart transplant recipients undergoing regular follow-up at our Institution between May 2022 and September 2023 were enrolled. All included patients underwent speckle tracking echocardiography, including MW indices. CAV was classified according to invasive coronary angiography or computed tomography performed within 12 months of index echocardiography. We collected all available clinical and echocardiographic parameters and evaluated potential association with CAV. CAV was detected in 29/93 (31%) patients (CAV+). Of the MW indices, mean global work efficiency (GWE) was 90±6%, and was significantly lower in CAV+ than CAV- subjects (86±7% vs 91±4%, p<0,001). GWE (OR 0.86; CI 0.77-0.94, p=0.002), E/e' ratio (OR 1.27; CI 1.08-1.52, p=0.006) and LVEF (OR 0.90; CI 0.81-0.98, p=0.017) were independently associated with the presence of CAV. GWE (GWE vs LV-GLS, delta AUC 0.154, p=0.047) and the proposed model (GWE+E/e' vs LV-GLS, delta AUC 0.198, p=0.004) were significantly superior in stratifying incremental risk for CAV compared to LV-GLS. In conclusion GWE was observed to be independently associated with the presence of CAV. MW could represent a novel non-invasive screening method for CAV in heart transplant recipients. Larger and prospective studies are needed to confirm this hypothesis.

Identifiants

pubmed: 39053724
pii: S0002-9149(24)00551-4
doi: 10.1016/j.amjcard.2024.07.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Giulio Cacioli (G)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.. Electronic address: giulio.cacioli@gmail.com.

Michele Ciabatti (M)

Cardiovascular Department, San Donato Hospital, Arezzo, Italy.

Ernesto Cristiano (E)

Department of Electrophysiology, Humanitas Gavazzeni, Bergamo, Italy.

Claudia Notari (C)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Ilaria Papisca (I)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Giada Distefano (G)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Giovanni Menafra (G)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Paola Lilla Della Monica (PLD)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Mariano Antonio Feccia (MA)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Amedeo Pergolini (A)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Viviana Maestrini (V)

Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Fabio Sbaraglia (F)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Federico Ranocchi (F)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Francesco Musumeci (F)

Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma.

Classifications MeSH